< Back to latest news & events

Articles

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

December 2022

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech industry. In advance of the main event, the Consumer Technology Association (CTA) distinguishes outstanding new products through the CES Innovation Awards, providing a first look at some of the most innovative technology to be exhibited at the upcoming conference.

The winners and honorees of the CES innovation awards for 2023 have been announced and showcase some exciting technology trends. As always health technology continues to be a huge theme, with three of the 2023 best of innovation winners providing products in the health tech space.

Korean blind-assistive start-up Dot Inc has received the accolade for its Dot Pad product, which was announced earlier this year. The Dot Pad is a tactile interface for the vision impaired to generate in real time not only braille text but other visual information such as images, handwriting and maps in a tactile format with controls to facilitate interaction with the graphics. A collaboration with Apple also means the Dot Pad integrates with the App store, iPad and iPhone. The Dot Pad is the first real-time tactile graphics display device on the market and the scale of innovation involved in its development is well supported by Dot Inc’s large IP portfolio for the product.

Dot Inc’s portfolio encompasses at the time of writing 86 granted patents across over 170 applications. As is typical with modern assistive devices, the portfolio spans not only a number of applications directed to the device’s unique hardware and information output mechanism, but also a large chunk of applications directed to the underlying software driving the control of the device. Mapping graphic information such as images to a tactile output is no simple feat, and Dot Inc have developed algorithms for content detection and tactile mapping to convert visual data into a spatial pattern of projections for the Dot Pad to output. Dot Inc’s portfolio includes a number of granted patents to the data processing aspect of the technology, for example US10217389B2.

Dot Inc is paving the way in accessible technology for the vision impaired and the Dot Pad symbolises a major step towards removing these barriers. According to the World Health Organisation around 40 million people globally are clinically blind, and so the market for assistive technology in this area doubtless has the potential to grow substantially. As more tech companies enter this space, the industry can act to further remove these barriers to interacting with the world whilst visually impaired.

Alongside the Dot Pad, two other innovative products in health tech also received the Best in Innovation award this year, each in the field of prevention or management of health conditions. Firstly, the Cray X exoskeleton from German Bionic is a wearable suit which provides support during lifting movement to prevent back injury in physically demanding jobs such as construction and logistics, as well as providing analytics on the wearer’s movement. Secondly, the AeviceMD from Singapore-based MedTech spinout Aevice Health, which is a smart wearable stethoscope for detecting abnormal lung sounds in home monitoring respiratory disorders.

It’s notable, if not surprising, that all three health tech winners this year utilise artificial intelligence somewhere in the featured product, reinforcing the predominance of AI in providing cutting edge solutions across the health tech space. No doubt we will see more innovative developments in this space at CES 2023 in January, which HGF electronics specialists Dr Chris Benson and Cassie Smith will be attending this year.

This blog was prepared by HGF Patent Attorney Cassie Smith.

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article